These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 22702743)
1. Live attenuated influenza vaccine (Fluenz™): a guide to its use in the prevention of seasonal influenza in children in the EU. Scott LJ; Carter NJ; Curran MP Paediatr Drugs; 2012 Aug; 14(4):271-9. PubMed ID: 22702743 [TBL] [Abstract][Full Text] [Related]
2. Live attenuated influenza vaccine (FluMist®; Fluenz™): a review of its use in the prevention of seasonal influenza in children and adults. Carter NJ; Curran MP Drugs; 2011 Aug; 71(12):1591-622. PubMed ID: 21861544 [TBL] [Abstract][Full Text] [Related]
3. Intranasal live attenuated seasonal influenza vaccine: does not challenge current practice. Prescrire Int; 2013 Sep; 22(141):201-4. PubMed ID: 24171209 [TBL] [Abstract][Full Text] [Related]
4. Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza. Ambrose CS; Luke C; Coelingh K Influenza Other Respir Viruses; 2008 Nov; 2(6):193-202. PubMed ID: 19453395 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive children. Bracco Neto H; Farhat CK; Tregnaghi MW; Madhi SA; Razmpour A; Palladino G; Small MG; Gruber WC; Forrest BD; Pediatr Infect Dis J; 2009 May; 28(5):365-71. PubMed ID: 19395948 [TBL] [Abstract][Full Text] [Related]
6. Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine. Belshe R; Lee MS; Walker RE; Stoddard J; Mendelman PM Expert Rev Vaccines; 2004 Dec; 3(6):643-54. PubMed ID: 15606348 [TBL] [Abstract][Full Text] [Related]
7. The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: a meta-analysis of 8 randomized controlled studies. Ambrose CS; Wu X; Knuf M; Wutzler P Vaccine; 2012 Jan; 30(5):886-92. PubMed ID: 22155144 [TBL] [Abstract][Full Text] [Related]
8. Safety of live attenuated influenza vaccine in mild to moderately immunocompromised children with cancer. Halasa N; Englund JA; Nachman S; Weinberg GA; Huber VC; Allison K; Dubovsky F; Yi T; McCullers JA; Flynn PM Vaccine; 2011 May; 29(24):4110-5. PubMed ID: 21496468 [TBL] [Abstract][Full Text] [Related]
9. Live attenuated influenza vaccine in children. Ambrose CS; Walker RE; Connor EM Semin Pediatr Infect Dis; 2006 Oct; 17(4):206-12. PubMed ID: 17055372 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of the safety of live attenuated influenza vaccine (LAIV) in children and adolescents with asthma and high-risk conditions: a population-based prospective cohort study conducted in England with the Clinical Practice Research Datalink. Caspard H; Steffey A; Mallory RM; Ambrose CS BMJ Open; 2018 Dec; 8(12):e023118. PubMed ID: 30530581 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and effectiveness of live attenuated influenza vaccine in school-age children. Coelingh K; Olajide IR; MacDonald P; Yogev R Expert Rev Vaccines; 2015; 14(10):1331-46. PubMed ID: 26372891 [TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and safety of a quadrivalent live attenuated influenza vaccine in children. Block SL; Falloon J; Hirschfield JA; Krilov LR; Dubovsky F; Yi T; Belshe RB Pediatr Infect Dis J; 2012 Jul; 31(7):745-51. PubMed ID: 22466322 [TBL] [Abstract][Full Text] [Related]
15. Live attenuated influenza vaccine for children. Drug Ther Bull; 2017 Oct; 55(10):114-117. PubMed ID: 29021248 [TBL] [Abstract][Full Text] [Related]
16. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal. Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Fleming DM; Crovari P; Wahn U; Klemola T; Schlesinger Y; Langussis A; Øymar K; Garcia ML; Krygier A; Costa H; Heininger U; Pregaldien JL; Cheng SM; Skinner J; Razmpour A; Saville M; Gruber WC; Forrest B; Pediatr Infect Dis J; 2006 Oct; 25(10):860-9. PubMed ID: 17006278 [TBL] [Abstract][Full Text] [Related]
18. Understanding Immunity in Children Vaccinated With Live Attenuated Influenza Vaccine. Shannon I; White CL; Nayak JL J Pediatric Infect Dis Soc; 2020 Mar; 9(Supplement_1):S10-S14. PubMed ID: 31848606 [TBL] [Abstract][Full Text] [Related]
19. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. Belshe RB; Mendelman PM; Treanor J; King J; Gruber WC; Piedra P; Bernstein DI; Hayden FG; Kotloff K; Zangwill K; Iacuzio D; Wolff M N Engl J Med; 1998 May; 338(20):1405-12. PubMed ID: 9580647 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of a Russian-backbone live attenuated influenza vaccine among young children in Bangladesh: a randomised, double-blind, placebo-controlled trial. Brooks WA; Zaman K; Lewis KD; Ortiz JR; Goswami D; Feser J; Sharmeen AT; Nahar K; Rahman M; Rahman MZ; Barin B; Yunus M; Fry AM; Bresee J; Azim T; Neuzil KM Lancet Glob Health; 2016 Dec; 4(12):e946-e954. PubMed ID: 27746226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]